AIMEE S WEISNER
CIK 1227308 · CVP, General Counsel · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.10M
Companies
5
Total Filings
56
Lifetime Open-Market Net
-$4.37M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LNSR | Director | 110,368 | $5.82 | $642.3K | $131.3K | 10 | 2026-06-05 |
| GKOS | Director | 22,684 | $126.81 | $2.88M | -$4.67M | 25 | 2026-06-01 |
| STAA | Director | 15,352 | $28.37 | $435.5K | $164.1K | 7 | 2024-06-24 |
| Oyster Point Pharma, Inc. (OYST) Delisted | Director | 3,573 | $11.17 | $39.9K | $0 | 5 | 2023-01-04 |
| EW | CVP, General Counsel | 1,675 | $85.11 | $142.6K | $0 | 3 | 2012-05-11 |
Recent Filings · Page 3 of 6
56 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-03-10 | GKOS | Exer (M) | +10,000 | $72.8K | EDGAR |
| 2023-01-04 | GKOS | Grant (A) | +1,572 | $0 | EDGAR |
| 2023-01-04 | Oyster Point Pharma, Inc. (OYST) Delisted | Disp (D) | −36,764 | $0 | EDGAR |
| 2022-06-17 | STAA | Exer (M) | — | $0 | EDGAR |
| 2022-06-08 | Oyster Point Pharma, Inc. (OYST) Delisted | Grant (A) | +3,573 | $0 | EDGAR |
| 2022-06-06 | GKOS | Grant (A) | +4,364 | $0 | EDGAR |
| 2022-05-27 | LNSR | Grant (A) | +4,285 | $0 | EDGAR |
| 2022-01-05 | GKOS | Grant (A) | +1,455 | $0 | EDGAR |
| 2021-08-09 | GKOS | Grant (A) | +2,000 | $103.3K | EDGAR |
| 2021-06-09 | Oyster Point Pharma, Inc. (OYST) Delisted | Grant (A) | +3,466 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.